Brittany Lovely

Articles

E-Selectin Represents Promising Direction for AML Treatment Focus

April 02, 2022

Investigators are seeking to overcome barriers to help patients with acute myeloid leukemia achieve complete and durable remissions by focusing their attention on novel agents engineered to target adhesion factors.